The TMRW Vault functions as an integrated cryogenic system, utilizing RFID-enabled CryoBeacons and the proprietary ivfOS software to manage oocytes, embryos, and sperm. By consolidating storage capacity—one tank occupies the footprint of three traditional dewars—the technology shifts clinic workflows from manual, paper-based identification to a continuous digital chain-of-custody. This oversight is further augmented by TMRW Overwatch, a monitoring service that conducts thousands of automated system checks daily.
Reprotech Secures CE Mark for TMRW Vault Cryogenic Storage
With the receipt of CE marking under the European Medical Device Regulation, Reprotech is clearing the path for the international expansion of its TMRW Vault system. The platform, designed to replace manual cryostorage with automated, digital tracking, aims to mitigate human error in fertility clinics across the European Union.
This regulatory milestone follows the April 2026 merger between Reprotech and TMRW Life Sciences, which combined a national U.S. biorepository network with advanced specimen management tech. Coupled with the 2025 acquisition of IMT Matcher, the company now offers a unified ecosystem for fertility centers that spans onsite storage, offsite cryopreservation, and digital witnessing. As clinics face rising volumes of reproductive tissues, this shift toward scalable, tech-enabled infrastructure targets the industry's long-standing reliance on manual storage systems, which historically presented significant risks for specimen traceability.
Comments (0)
No comments yet. Be the first!